SCHEMBL10334136

SCHEMBL10334136

CC(=O)Oc1ccc2ccccc2c1C

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCEH1 Q6PIU2 10/20 0.71
HTT P42858 2/20 0.51
MEN1 O00255 1/20 0.49
NPC1 O15118 1/20 0.49
MAPT P10636 1/20 0.49
RAB9A P51151 1/20 0.49
KMT2A Q03164 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
ACHE P22303 1/20 0.49
SLC22A6 Q4U2R8 1/20 0.49
TSHR P16473 2/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2A6 P11509 1/20 0.48
LMNA P02545 1/20 0.47
GAA P10253 2/20 0.47
NPSR1 Q6W5P4 1/20 0.47
GPR55 Q9Y2T6 1/20 0.47
ALDH1A1 P00352 2/20 0.46
PTGS1 P23219 2/20 0.46
HSD17B10 Q99714 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27473587 0.86 NCEH1 (0.67) NCEH1NPC1MAPTRAB9ASMN1; SMN2
SCHEMBL30710587 0.85 MAPT (0.58) NCEH1HTTMAPTSLC22A6TSHR
SCHEMBL12199931 0.85 MAPT (0.58) NCEH1HTTMAPTSLC22A6TSHR
SCHEMBL29963395 0.84 NCEH1 (0.53) NCEH1HTTMEN1NPC1MAPT
SCHEMBL9683874 0.84 NCEH1 (0.51) NCEH1HTTNPC1MAPTRAB9A
SCHEMBL6142391 0.84 NCEH1 (0.51) NCEH1HTTMEN1NPC1MAPT
SCHEMBL9488962 0.84 HTT (0.54) NCEH1HTTMAPTKMT2ASLC22A6
SCHEMBL25969910 0.83 NCEH1 (0.63) NCEH1MEN1NPC1MAPTRAB9A
SCHEMBL23930399 0.82 NCEH1 (0.72) NCEH1HTTNPC1MAPTRAB9A
SCHEMBL29946533 0.82 NCEH1 (0.69) NCEH1HTTNPC1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020247608-A1 SMALL MOLECULE INHIBITORS OF A PROTEIN COMPLEX THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2020-12-10 WO disclosed
CN-109312025-A The method for being used to prepare organic charge transport film 陶氏环球技术有限责任公司 2019-02-05 CN disclosed
US-20100286360-A1 POLYMER COMPOUND AND POLYMER LIGHT EMITTING DEVICE USING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-11-11 US disclosed
US-20100286360-A1 POLYMER COMPOUND AND POLYMER LIGHT EMITTING DEVICE USING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-11-11 US disclosed
US-20070032525-A1 Piperidine derivatives having ccr3 antagonism TEIJIN LIMITED, A JAPANESE BODY CORPORATE (JP) 2007-02-08 US disclosed
CN-1724597-A Phase change inks XEROX CORP (US) 2006-01-25 CN disclosed
US-4904752-A Liquid crystal copolyester having blocked molecular chain terminal POLYPLASTICS CO., LTD. (JP) 1990-02-27 US disclosed
EP-0269321-A2 Liquid crystal copolyesters having a blocked terminal of its molecular chain POLYPLASTICS CO. LTD. (JP) 1988-06-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286360-A1 POLYMER COMPOUND AND POLYMER LIGHT EMITTING DEVICE USING THE SAME IGF1R, SCO2, CRY1 NCEH1 3255/4885HTT 4114/4885MEN1 725/4885
US-20070032525-A1 Piperidine derivatives having ccr3 antagonism CCR3, CCR1, CCR4 NCEH1 726/4885HTT 3359/4885MEN1 3556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.